Median Technologies SA

Paris Stock Exchange ALMDT.PA

Median Technologies SA Cash and Short-Term Investments for the year ending December 31, 2023: USD 21.67 M

Median Technologies SA Cash and Short-Term Investments is USD 21.67 M for the year ending December 31, 2023, a -6.56% change year over year. Cash and short-term investments are the sum of cash and short-term investments, representing the company's liquid assets.
  • Median Technologies SA Cash and Short-Term Investments for the year ending December 31, 2022 was USD 23.19 M, a -48.10% change year over year.
  • Median Technologies SA Cash and Short-Term Investments for the year ending December 31, 2021 was USD 44.68 M, a 123.06% change year over year.
  • Median Technologies SA Cash and Short-Term Investments for the year ending December 31, 2020 was USD 20.03 M, a 130.14% change year over year.
  • Median Technologies SA Cash and Short-Term Investments for the year ending December 31, 2019 was USD 8.70 M, a -40.74% change year over year.
Key data
Date Cash and Short-Term Investments Receivables Inventory Goodwill
Market news
Loading...
Paris Stock Exchange: ALMDT.PA

Median Technologies SA

CEO Mr. Fredrik Brag
IPO Date May 20, 2011
Location France
Headquarters 1800, Route des CrEtes
Employees 250
Sector Technology
Industries
Description

Median Technologies SA develops and markets software products and platforms for medical image analysis in France, the United States, Canada, the United Kingdom, China, and internationally. The company offers iBiops, an end-to-end AI-powered technology software as a medical device that integrates and optimizes the entire medical imaging workflow; and iSee for image analysis services in clinical trials. It also provides imaging contract research services, such as study start up, image and clinical data management, scientific consulting, independent reviews, image data processing and site support, and study close-out for studies. Median Technologies SA has a research collaboration agreement with the University of California. The company was founded in 2002 and is based in Valbonne, France.

Similar companies

ALBIO.PA

Biosynex SA

USD 2.27

11.78%

ALKAL.PA

Kalray S.A.

USD 0.86

-0.59%

OSE.PA

OSE Immunotherapeutics SA

USD 6.91

0.46%

ALERS.PA

Eurobio Scientific Société anonyme

USD 26.07

0.60%

StockViz Staff

January 15, 2025

Any question? Send us an email